Eric dEsparbes - 15 May 2022 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role: Chief Financial Officer
Signature: /s/ Will Pridgen, Attorney-in-Fact for Eric d'Esparbes
Issuer symbol: BIORQ
Transactions as of: 15 May 2022
Net transactions value: -$7,790
Form type: 4
Filing time: 17 May 2022, 17:18:56 UTC
Previous filing: 19 Apr 2022
Next filing: 16 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIOR	Common Stock	Tax liability	$7,790	-10,387	-2.5%	$0.7500	412,784	15 May 2022	Direct	F1
transaction	BIOR	Common Stock	Award	$0	+292,406	+71%	$0.000000	705,190	15 May 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOR	Stock Option (Right to Buy)	Award	$0	+472,495		$0.000000	472,495	15 May 2022	Common Stock	472,495	$0.7500	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 20,948 vested restricted stock units on May 15, 2022.
F2	Consists of 292,406 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer.
F3	This option represents the right to purchase 472,495 shares of the Issuer's common stock, 9,843 of which vested upon grant, with the remaining shares vesting in equal monthly installments through April 15, 2026, subject to the Reporting Person's continued service to the Issuer.